Abstract
The impact of pre-diabetes on clinical status was retrospectively studied in 38 cystic fibrosis (CF) patients with diabetes mellitus (DM) and 38 non-diabetic CF patients (control patients), matched in pairs for age, sex, and chronicPseudomonas aeruginosa lung infection. Quarterly parameters of CF clinical status were collected for 6 years prior to the diagnosis of DM in the index case. Compared to the control patients, decreases in body weight, body mass index (BMI), forced expiratory volume in 1s (FEV1), and forced vital capacity (FVC) and an increase in the daily intake of pancreatic enzyme capsules were found in the pre-diabetic patients. Statistically significant differences in body weight, BMI, FEV1, FVC, and intake of pancreatic enzyme capsules between pre-diabetic and control patients emerged 4, 4, 1.25, 3 and 4.5 years prior to the diagnosis of DM, respectively. The number of lung infections did not differ between the two groups of patients. Thus, when DM develops in CF patients, an insidious decline in overall clinical status is observed for years prior to its diagnosis. Whether clinical deterioration in CF leads to DM, or pre-diabetes results in declining CF clinical status is presently unknown. Accumulating evidence suggests that the latter may be the case since insulin therapy seems to improve lung function in CF.
Similar content being viewed by others
Abbreviations
- CF:
-
cystic fibrosis
- DM:
-
diabetes mellitus
- BMI:
-
body mass index
- FEV1 :
-
forced expiratory volume in 1s
- FVC:
-
forced vital capacity
References
Bistritzer T, Sack J, Eshkol A, Katznelson D (1983) Hemoglobin A1 and pancreatic beta cell function in cystic fibrosis. Isr J Med Sci 19:600–603
Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu S-C, Klein DJ (1988) Diabetes mellitus associated with cystic fibrosis. J Pediatr 112:373–377
Frier B, Faber OK, Binder C, Elliott HL (1978) The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus. Diabetologia 14:301–304
Handwerger S, Roth J, Gorden P, Di Sant'Agnese P, Carpenter DF, Peter G (1969) Glucose intolerance in cystic fibrosis. N Engl J Med 281:451–461
Hoskins PJ, Leslie RDG, Pyke DA (1985) Height at diagnosis of diabetes in children: a study in identical twins. BMJ 290:278–280
Høiby N (1977)Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance ofPseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Path Microbiol Scand. Section C, Immunology 85 [Suppl 262]:3–96
Høiby N, Pedersen SS (1989) Estimated risk of cross-infection withPseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand 78:395–404
Johansen HK, Nir M, Høiby N, Koch C, Schwartz M (1991) Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation. Lancet 337:631–634
Lange P, Groth S, Kastrup J, Mortensen J, Appleyard M, Nyboe J, Jensen G, Schnohr P (1989) Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Respir J 2:14–19
Lange P, Groth S, Mortensen J, Appleyard M, Nyboe J, Schnohr P, Jensen G (1990) Diabetes mellitus and ventilatory capacity: a five year follow-up study. Eur Respir J 3:288–292
Lanng S, Schwartz M, Thorsteinsson B, Koch C (1991) Endocrine and exocrine pancreatic function and the ΔF508 mutation in cystic fibrosis. Clin Genet 40:345–348
Lanng S, Thorsteinsson B, Nerup J, Koch C (1991) Glucose tolerance in cystic fibrosis. Arch Dis Child 66:612–616
Lanng S, Thorsteinsson B, Nerup J, Koch C (1991) Diabetes mellitus and lung function in cystic fibrosis. Diabetes 40 [Suppl 1]:525A
Leslie RDG, Lo S, Millward BA, Honour J, Pyke DA (1991) Decreased growth velocity before IDDM onset. Diabetes 40:211–216
Milner AD (1969) Blood glucose and serum insulin levels in children with cystic fibrosis. Arch Dis Child 44:351–355
Polgar G, Promadhat V (1971) Pulmonary function testing in children: techniques and standards. WB Saunders, Philadelphia, pp 88–107, 178–182
Reisman J, Corey M, Canny G, Levison H (1990) Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics 86:374–377
Rodman HM, Doershuk CF, Roland JM (1986) The interaction of 2 diseases: diabetes mellitus and cystic fibrosis. Medicine 65:389–397
Schwartz M, Johansen HK, Koch C, Brandt NJ (1990) Frequency of the ΔF508 mutation on cystic fibrosis chromosomes in Denmark. Hum Genet 85:427–428
Stutchfield PR, O'Halloran S, Teale JD, Isherwood D, Smith CS, Heaf D (1987) Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child 62:805–810
Thorsteinsson B, Lanng S, Nerup J, Koch C (1991) Epidemiology of glucose intolerance in cystic fibrosis. Diabetes 40 [Suppl 1]: 320A
Wilson RM (1991) Infection and diabetes mellitus. In Pickup JC, Williams G (eds) Textbook of Diabetes. Blackwell Scientific Publications, Oxford, pp 813–819
World Health Organization Study Group (1985) Diabetes mellitus. WHO Tech Rep Ser 727:1–113
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lanng, S., Thorsteinsson, B., Nerup, J. et al. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 151, 684–687 (1992). https://doi.org/10.1007/BF01957574
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01957574